Proteins like ORM1 and OVGP1 might influence MM progression through multiple mechanisms, for example, by modulating immune evasion, affecting cell adhesion in the marrow niche, or altering sensitivity to other drugs. Here, OVGP1 is linked to Miyoshi myopathy.